BioLive Japan
From April 19, 2023 until April 21, 2023
At Koto - Tokyo Big Sight, Tokyo, Japan
Posted by Canton Fair Net
https://www.cphi.com/japan/en/Sub-Events/biolive.html
Categories: Medical & Pharma
Hits: 6319
CPhI Japan | BioLIVE | Japan’s Pharma Market Awaits You
Japan's biopharmaceutical industry. Why is BioLIVE Japan so great? Caution: Exhibitors. CPhI 365 Digital Solutions.
This is part of Informa Markets Division at Informa PLC.
Informa PLC owns this site and all copyright is theirs. Informa PLC is located at 5 Howick Place in London SW1P 1WG. Registered in England and Wales. Number 8860726.
Japan's most important biotech event, bioLIVE, focuses on biopharmaceutical innovations and services and is an essential place for overseas and Japanese pharmaceutical professionals.
Japan's biopharmaceutical market is growing rapidly, with more than 70% of the approved biopharmaceuticals being supplied by foreign companies. Japan's pharmaceutical industry has been based on innovation and patent drugs. However, experts are now seeing a significant increase in generics, biosimilars, and increased cooperation between Japanese pharma companies and global partners. This is driving innovation.
These companies hosted buyers in 2018
Meiji Seika Pharma | Astellas Pharma | Eisai | Takeda Pharmaceutical Company | AIICHI SANKYO COMPANY | Kyowa Kirin | FUJIFILM Corporation | CHUGAI PHARMACEUTICAL | ONO PHARMACEUTICAL | Otsuka Pharmaceutical.
This is a great spot to meet existing clients and potential customers. It's all about expanding our business in Asia.
Thomas Jung, Vice President - Business Development, KBI Biopharma Inc.
Bushu and Suzuken join forces to help manufacturers look for the Japanese market.